Huang James
SEC-identified person · CIK 1573160 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Connect Biopharma Holdings Ltd CNTB | Director | filed 2026 - 2026 |
| Atara Biotherapeutics, Inc. ATRA | Director | filed 2025 - 2026 |
| Casi Pharmaceuticals, Inc. CASIF | Director | filed 2026 - 2026 |
| Ziopharm Oncology INC ZIOP | Director | filed 2020 - 2023 |
| Orion Biotech Opportunities Corp. ORIA | Director · Chief Executive Officer | filed 2021 - 2023 |
| Windtree Therapeutics INC /DE/ dsco | Director | filed 2018 - 2023 |
| Entremed INC ENMD | Director | filed 2013 - 2022 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.